Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Cytarabine
Related studies linked through entity extraction aliases.
BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2181308 Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis
- Status
- COMPLETED
- Phase
- PHASE2
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
- Status
- UNKNOWN
- Phase
- NA
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R
- Status
- COMPLETED
- Phase
- PHASE2
Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2